• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Collagen crosslinking may have role in postRK progressive hyperopia

Article

Collagen crosslinking is showing promise as a method for arresting progressive hyperopia after radial keratotomy (RK) and laser ablation, said Brian S. Boxer Wachler, MD, at Refractive Surgery 2006.

Collagen crosslinking is showing promise as a method for arresting progressive hyperopia after radial keratotomy (RK) and laser ablation, said Brian S. Boxer Wachler, MD, at Refractive Surgery 2006.

He reported results from 6 eyes of patients with a mean age of 51 years. All had been treated with laser vision correction for progressive hyperopia after RK, but experienced further progression, said Dr. Boxer Wachler, director, Boxer Wachler Vision Institute, Beverly Hills, CA.

After a mean follow-up of 215 days (range, 30 to 450 days), there have been no significant changes in endothelial cell count, and no eye has experienced more than 1 D of change in sphere or refractive cylinder. Corneal topography also showed no worsening and even a slight steepening on average.

"The change in keratometry makes sense if we consider RK weakens and flattens the cornea and that this procedure may be tightening the incisions to steepen the cornea," he said.

He concluded with cautious optimism.

"Further study is needed in more patients and with longer term follow-up," Dr. Boxer Wachler said. "Based on these preliminary results, we are hopeful that stabilization is occurring and that this might be a nice treatment to offer patients who are suffering from progressive hyperopia after RK."

Related Videos
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.